Aniline analogs as glycogen synthase activators
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Hoffmann-La Roche Inc.
C A A C A C A C C C C A C A
C07C A61K A61K C07C A61P C07C A61K C07C C07D C07C C07C A61P C07D A61K
inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Matthew Michael David Robert
Hamilton Bolin